Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of factors associated with aggressive end-of-life antitumour treatment: retrospective study of 1282 patients with cancer.
BMJ Support Palliat Care. 2020 Nov 5:bmjspcare-2020-002635. doi: 10.1136/bmjspcare-2020-002635. Online ahead of print.
BMJ Support Palliat Care. 2020.
PMID: 33154087
Impact of ferric carboxymaltose on the evolution of hemoglobin and ECOG performance status in iron-deficient patients with solid tumors: a 3-month follow-up retrospective study.
Coussirou J, Debourdeau A, Stancu A, Jean C, Azouza W, Chanet B, De Crozals F, Boustany R, Debourdeau P.
Coussirou J, et al.
Support Care Cancer. 2018 Nov;26(11):3827-3834. doi: 10.1007/s00520-018-4250-x. Epub 2018 May 24.
Support Care Cancer. 2018.
PMID: 29797080
Item in Clipboard
[Needs assessment for the establishment of an Oral Therapy Unit].
Vazquez L, Coussirou J, Grenier J, Billemont B, Mege A, de Rauglaudre G, Stancu A, David C, Durand A, Decrozals F, Arnaud A.
Vazquez L, et al. Among authors: coussirou j.
Bull Cancer. 2023 Feb;110(2):184-192. doi: 10.1016/j.bulcan.2022.10.005. Epub 2022 Nov 18.
Bull Cancer. 2023.
PMID: 36411129
French.
Item in Clipboard
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.
Loret EP, et al. Among authors: coussirou j.
Retrovirology. 2016 May 9;13(1):35. doi: 10.1186/s12977-016-0264-y.
Retrovirology. 2016.
PMID: 27160192
Free PMC article.
No abstract available.
Item in Clipboard
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.
Loret EP, et al. Among authors: coussirou j.
Retrovirology. 2016 Apr 1;13:21. doi: 10.1186/s12977-016-0251-3.
Retrovirology. 2016.
PMID: 27036656
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite